Please assess the completion status of the following clinical trial:

Trial Title: Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Elderly patients (\>68 and \<82 years) with atrial fibrillation and adequate oral anticoagulation therapy and cholesterol levels between 4,5 mmol/l and 7 mmol/l~Exclusion Criteria:~* Indication for cholesterol lowering treatment according to Dutch CBO-cholesterol guidelines (2004)

- Gender: ALL
- Minimum Age: 68 Years
- Maximum Age: 82 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).